SERA), a company with a market capitalization of $137.45 million, executed a stock sale valued at approximately $27,090, according to a recent SEC filing. On February 12, Austin sold 5,915 shares ...

Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing ...

SALT LAKE CITY, May 7, 2025 /PRNewswire/ -- Sera Prognostics Inc. , The Pregnancy Company ® (Nasdaq: SERA ), focused on improving maternal and neonatal health by providing innovative pregnancy ...

Sera Prognostics, Inc. engages in the provision ... preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and ...

SALT LAKE CITY - Sera Prognostics Inc. (NASDAQ:SERA), a company focused on improving maternal and neonatal health through innovative biomarker tests, has appointed Lee Anderson as its new Chief ...

SALT LAKE CITY - Sera Prognostics Inc. (NASDAQ:SERA), a company focused on improving maternal and neonatal health through innovative biomarker tests, has appointed Lee Anderson as its new Chief ...

Industry Veteran to Spearhead Commercial Expansion, Driving Innovation and Growth at the Company SALT LAKE CITY, May 8, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® ...